AAAAAA
Results:
1-23
|
Results: 23
Authors:
Conner-Spady, B
Cumming, C
Nabholtz, JM
Jacobs, P
Stewart, D
Citation: B. Conner-spady et al., Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy, QUAL LIFE R, 10(6), 2001, pp. 479-486
Authors:
Nabholtz, JM
Bonneterre, J
Buzdar, A
Robertson, JFR
Thurlimann, B
Steinberg, M
Webster, A
von Euler, M
Citation: Jm. Nabholtz et al., Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer? Reply, J CL ONCOL, 19(9), 2001, pp. 2580-2582
Authors:
Nabholtz, JM
Mackey, JR
Smylie, M
Paterson, A
Noel, DR
Al-Tweigeri, T
Tonkin, K
North, S
Azli, N
Riva, A
Citation: Jm. Nabholtz et al., Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer, J CL ONCOL, 19(2), 2001, pp. 314-321
Authors:
Nabholtz, JM
Citation: Jm. Nabholtz, Docetaxel (Taxotere (R)) combined with anthracycline, Xeloda (R) and new pharmaceuticals, TUMORI, 87(1), 2001, pp. S1-S9
Authors:
Parliament, M
Jha, N
Rapp, E
Smith, C
MacKinnon, J
Nabholtz, JM
Hanson, J
Reiman, T
Mackey, J
Citation: M. Parliament et al., Concurrent weekly carboplatin and radiotherapy for nasopharyngeal carcinoma: report of a joint phase II study, RADIOTH ONC, 58(2), 2001, pp. 131-136
Authors:
Nabholtz, JM
Slamon, D
Citation: Jm. Nabholtz et D. Slamon, New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin), SEMIN ONCOL, 28(1), 2001, pp. 1-12
Authors:
Baum, M
Dowsett, M
Coibion, M
Bianco, AR
Cuzick, J
George, WD
Gray, J
Howell, A
Houghton, J
Williams, N
Sloane, J
Tobias, J
Buzdar, A
Anderson, MD
Jackson, I
Sahmoud, T
Gallagher, J
Webster, A
Gangji, D
Petrakova, K
Konopasek, B
Mares, P
Vodvarka, P
Alcazar, A
Campos, O
Maxwell, A",Goedhals,"Hacking, D
Landers, G
Smith, L
Vorobiof, DA
Werner, ID
Blamey, R
Coleman, R
Grieve, RJ
Hickish, T
Howell, A
Nicholls, JC
Nicholson, S
Raymond, S
Salman, A
Blum, J
Clark, R
Lyss, A
Miletello, G
Sternberg, J
Forbes, J
Coibion, M
Nabholtz, JM
Guastalla, JP
Distler, W
Klijn, JGM
Nagykalnai, T
Nicolucci, A
Bianco, AR
Constenla, M
Nylen, U
Howell, A
Sainsbury, R
Mansel, RE
Goerge, D
Buzdar, AU
Locker, GY
Gallagher, J
Jackson, I
Sahmoud, T
Houghton, J
Williams, N
Nicolucci, A
Pollard, S
Stroner, P
Buyse, M
Margolese, R
Northover, JMA
Citation: M. Baum et al., Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex (TM) and Tamoxifen Alone or in Combination' (ATAC) trial, BR J CANC, 85(3), 2001, pp. 317-324
Authors:
Mackey, JR
Wood, L
Nabholtz, JM
Jensen, J
Venner, P
Citation: Jr. Mackey et al., A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites, J PAIN SYMP, 19(3), 2000, pp. 193-199
Authors:
Nabholtz, JM
Buzdar, A
Pollak, M
Harwin, W
Burton, G
Mangalik, A
Steinberg, M
Webster, A
von Euler, M
Citation: Jm. Nabholtz et al., Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: Results of a North American multicenter randomized trial, J CL ONCOL, 18(22), 2000, pp. 3758-3767
Authors:
Nabholtz, JM
Citation: Jm. Nabholtz, Docetaxel in the adjuvant setting, ONKOLOGIE, 23, 2000, pp. 10-12
Authors:
Fields, KK
Crump, M
Bence-Bruckler, I
Bernstein, S
Williams, S
Frankel, S
Miller, A
Demetri, G
Nabholtz, JM
Cruickshank, S
Lill, M
Citation: Kk. Fields et al., Use of PEG-rHuMGDF in platelet engraftment after autologous stem cell transplantation, BONE MAR TR, 26(10), 2000, pp. 1083-1088
Authors:
Goss, PE
Strasser, K
Marques, R
Clemons, M
Oza, A
Goel, R
Blackstein, M
Kaizer, L
Sterns, EE
Nabholtz, JM
De Coster, R
Crump, M
Abdolell, M
Qi, S
Citation: Pe. Goss et al., Liarozole fumarate (R85246): In the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer, BREAST CANC, 64(2), 2000, pp. 177-188
Authors:
Goss, PE
Oza, A
Goel, R
Nabholtz, JM
De Coster, R
Bruynseels, J
Reid, C
Wadden, N
Crump, M
Tye, LM
Citation: Pe. Goss et al., Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer, BREAST CANC, 59(1), 2000, pp. 55-68
Authors:
Nabholtz, JM
North, S
Smylie, M
Mackey, J
Au, HJ
Au, R
Morrish, D
Salter, E
Tonkin, K
Citation: Jm. Nabholtz et al., Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer, SEMIN ONCOL, 27(2), 2000, pp. 11-18
Authors:
Nabholtz, JM
Senn, HJ
Bezwoda, WR
Melnychuk, D
Deschenes, L
Douma, J
Vandenberg, TA
Rapoport, B
Rosso, R
Trillet-Lenoir, V
Drbal, J
Molino, A
Nortier, JWR
Richel, DJ
Nagykalnai, T
Siedlecki, P
Wilking, N
Genot, JY
Hupperets, PSGJ
Pannuti, F
Skarlos, D
Tomiak, EM
Murawsky, M
Alakl, M
Riva, A
Aapro, M
Citation: Jm. Nabholtz et al., Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy, J CL ONCOL, 17(5), 1999, pp. 1413-1424
Authors:
Nabholtz, JM
Citation: Jm. Nabholtz, Docetaxel (Taxotere) plus doxorubicin-based combinations: The evidence of activity in breast cancer, SEMIN ONCOL, 26(3), 1999, pp. 7-13
Authors:
Nabholtz, JM
Citation: Jm. Nabholtz, The role of taxanes in the management of breast cancer, SEMIN ONCOL, 26(3), 1999, pp. 1-3
Authors:
Nabholtz, JM
Lindsay, MA
Hugh, J
Mackey, J
Smylie, M
Au, HJ
Tonkin, K
Allen, M
Citation: Jm. Nabholtz et al., The academic global virtual concept in clinical cancer research and its application to breast cancer: The breast cancer international research group, SEMIN ONCOL, 26(3), 1999, pp. 4-8
Authors:
Nabholtz, JM
Smylie, M
Mackey, J
Au, HJ
Tonkin, K
Au, R
Morrish, D
Salter, E
Citation: Jm. Nabholtz et al., Docetaxel and anthracycline polychemotherapy in the treatment of breast cancer, SEMIN ONCOL, 26(3), 1999, pp. 47-52
Authors:
Nabholtz, JM
Tonkin, K
Smylie, M
Mackey, J
Janowska-Wieczorek, A
Citation: Jm. Nabholtz et al., Review of docetaxel and doxorubicin-based combinations in the management of breast cancer: From metastatic to adjuvant setting, SEMIN ONCOL, 26(1), 1999, pp. 10-16
Authors:
Janowska-Wieczorek, A
Marquez, LA
Nabholtz, JM
Cabuhat, ML
Montano, J
Chang, H
Rozmus, J
Russell, JA
Edwards, DR
Turner, AR
Citation: A. Janowska-wieczorek et al., Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane, BLOOD, 93(10), 1999, pp. 3379-3390
Authors:
Nabholtz, JM
Crown, J
Citation: Jm. Nabholtz et J. Crown, Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: Preliminary results, SEMIN ONCOL, 25(6), 1998, pp. 4-9
Authors:
Nabholtz, JM
Mackey, J
Smylie, M
Tonkin, K
Citation: Jm. Nabholtz et al., Taxane-based three-drug combination in metastatic and adjuvant treatment of breast cancer, SEMIN ONCOL, 25(5), 1998, pp. 27-31
Risultati:
1-23
|